May 8, 2015Open Access

MicroRNA‐125b attenuates epithelial‐mesenchymal transitions and targets stem‐like liver cancer cells through small mothers against decapentaplegic 2 and 4

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

miR-125b exerts inhibitory effects on EMT and EMT-associated traits in HCC by SMAD2 and 4. Ectopic expression of miR-125b provides a promising strategy to treat HCC.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Zhou et al. (Fri,) studied this question.

synapsesocial.com/papers/69dd2cea0644c7b49d40c454 https://doi.org/https://doi.org/10.1002/hep.27887

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer2011 · 170 citations
2Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray2003 · 246 citations
3MiR-125 in normal and malignant hematopoiesis2012 · 189 citations
4Cancer Stem Cell as a Potential Therapeutic Target in Hepatocellular Carcinoma2012 · 50 citations
5Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: Role of the S100A4-miR155-SOCS1-MMP9 axis2013 · 179 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo